Abstract

IntroductionRecent data indicate that transfusion of packed red blood cells (pRBCs) may increase the risk for the development of acute respiratory distress syndrome (ARDS) in critically ill patients. Uncertainty remains regarding the strength of this relationship.MethodsTo quantify the association between transfusions and intensive care unit (ICU)-onset ARDS, we performed a cohort study within Crit, a multicenter, prospective, observational study of transfusion practice in the ICU which enrolled 4,892 critically ill patients in 284 ICUs in the United States. Diagnostic criteria for ARDS were prospectively defined, and we focused on subjects without ARDS at admission. The development of ARDS in the ICU served as the primary endpoint.ResultsAmong the 4,730 patients without ARDS at admission, 246 (5.2%) developed ARDS in the ICU. At baseline, ARDS cases were younger, more likely to be in a surgical ICU, and more likely to be admitted with pneumonia or sepsis than controls without ARDS. Cases also were more likely to have a serum creatinine of greater than 2.0 mg/dl (23% versus 18%) and a serum albumin of less than or equal to 2.3 g/dl (54% versus 30%) and were more severely ill upon ICU admission as measured by either the APACHE II (Acute Physiology and Chronic Health Evaluation II) or SOFA (Sequential Organ Failure Assessment) score (p < 0.05 for all). Sixty-seven percent and 42% of cases and controls, respectively, had exposure to pRBC transfusions (p < 0.05), and the unadjusted odds ratio (OR) of developing ARDS in transfused patients was 2.74 (95% confidence interval [CI], 2.09 to 3.59; p < 0.0001) compared to those never transfused. After age, baseline severity of illness, admitting diagnosis, and process-of-care factors were adjusted for, the independent relationship between pRBC transfusions and ICU-onset ARDS remained significant (adjusted OR, 2.80; 95% CI, 1.90 to 4.12; p < 0.0001).ConclusionDevelopment of ARDS after ICU admission is common, occurring in approximately 5% of critically ill patients. Transfusion of pRBCs is independently associated with the development of ARDS in the ICU.

Highlights

  • Recent data indicate that transfusion of packed red blood cells may increase the risk for the development of acute respiratory distress syndrome (ARDS) in critically ill patients

  • ARDS cases were younger, more likely to be in a surgical intensive care unit (ICU), and more likely to be admitted with pneumonia or sepsis than controls without ARDS

  • Sixty-seven percent and 42% of cases and controls, respectively, had exposure to packed red blood cells (pRBCs) transfusions (p < 0.05), and the unadjusted odds ratio (OR) of developing ARDS in transfused patients was 2.74 (95% confidence interval [confidence intervals (CIs)], 2.09 to 3.59; p < 0.0001) compared to those never transfused

Read more

Summary

Introduction

Recent data indicate that transfusion of packed red blood cells (pRBCs) may increase the risk for the development of acute respiratory distress syndrome (ARDS) in critically ill patients. Acute respiratory distress syndrome (ARDS) remains a frequent complication of critical illness and is associated with significant morbidity and mortality. Because the manner in which care is delivered to at-risk patients may contribute to ARDS development, there is a need to better understand process-of-care variables in APACHE II = Acute Physiology and Chronic Health Evaluation II; ARDS = acute respiratory distress syndrome; CI = confidence interval; ICU = intensive care unit; OR = odds ratio; pRBC = packed red blood cell; SIRS = systemic inflammatory response syndrome; SOFA = Sequential Organ Failure Assessment; TRALI = transfusion-related acute lung injury. PRBC transfusion alters host defenses, which might predispose to ARDS [13,14]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call